Concord Wealth Partners lifted its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 29.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 44,297 shares of the company’s stock after purchasing an additional 9,991 shares during the period. Merck & Co., Inc. accounts […]

Barrett & Company Inc. cut its position in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 19.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 440 shares of the company’s stock after selling 107 shares during the quarter. Barrett & Company Inc.’s holdings […]

Montz Harcus Wealth Management LLC lowered its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 6.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 3,208 shares of the company’s stock after selling 212 shares during the period. Montz Harcus Wealth Management LLC’s […]

CWC Advisors LLC. purchased a new stake in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 419 shares of the company’s stock, valued at approximately $242,000. Other hedge […]

Fortune Financial Advisors LLC trimmed its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 92.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,014 shares of the company’s stock after selling 38,871 shares during the quarter. Fortune […]

Frank Rimerman Advisors LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,843 shares of the healthcare product maker’s stock after selling 765 shares during the quarter. […]